BRIEF published on 04/15/2026 at 18:59, 5 months 2 days ago Publication of the 2025 Universal Registration Document by Ipsos AMF Financial Report 2025 Registration Document Ipsos
BRIEF published on 03/26/2026 at 17:54, 5 months 22 days ago Ipsos: Declaration of shares and voting rights for February 2026 Share Capital Voting Rights AMF Financial Transparency Ipsos Shares
BRIEF published on 03/26/2026 at 17:54, 5 months 22 days ago IPSOS Reports Shares and Voting Rights for February 2026 Voting Rights Shares AMF Regulations Ipsos February 2026
PRESS RELEASE published on 03/26/2026 at 17:49, 5 months 22 days ago Ipsos: Monthly declaration of shares and voting rights - February 2026 Ipsos discloses total number of shares and voting rights for February 28, 2026, as required by regulations Voting Rights Shares Disclosure Regulations Ipsos
BRIEF published on 02/27/2026 at 18:51, 6 months 18 days ago Ipsos Sells 80% Stake in Russian Subsidiary Ipsos Comcon LLC Divestment Market Research Russia Ipsos Ownership Law
PRESS RELEASE published on 02/27/2026 at 18:46, 6 months 18 days ago [Press Release] Sale of 80% of Ipsos Comcon LLC - Ipsos’ subsidiary in Russia Ipsos SA announces the sale of 80% of Ipsos ComCon LLC, its subsidiary in Russia, to Direct Investments JSC, complying with Russian regulations. Ipsos retains 20% passive ownership Sale Market Research Russia Ipsos Direct Investments JSC
BRIEF published on 02/25/2026 at 17:50, 6 months 20 days ago January 2026 Share and Voting Rights Disclosure by Ipsos Voting Rights Shares AMF Regulation Ipsos January 2026
PRESS RELEASE published on 02/25/2026 at 17:45, 6 months 20 days ago Ipsos: Monthly declaration of shares and voting rights - January 2026 Ipsos releases monthly disclosure of total shares and voting rights as per regulatory requirements Voting Rights Shares Regulatory Requirements Monthly Disclosure Ipsos
BRIEF published on 02/24/2026 at 20:20, 6 months 21 days ago Ipsos Discloses Share Buyback Transactions Ordinary Shares Shareholder Value Share Buyback Ipsos Trading Platforms
BRIEF published on 02/24/2026 at 20:20, 6 months 21 days ago Share buyback at Ipsos: Activity from February 16 to 20, 2026 Share Buyback Financial Markets Average Price Ipsos Feb 2026
Published on 09/18/2026 at 00:55, 2 hours 1 minute ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 2 hours 31 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 4 hours 41 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/17/2026 at 22:15, 4 hours 41 minutes ago Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders
Published on 09/17/2026 at 22:05, 4 hours 51 minutes ago Loop Industries Forms Strategic Alternatives Committee to Maximize Shareholder Value
Published on 09/17/2026 at 19:00, 7 hours 55 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 7 hours 57 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 8 hours 30 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 8 hours 45 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 9 hours 9 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 9 hours 16 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 9 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 19 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
